{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T09:06:23Z","timestamp":1779181583622,"version":"3.51.4"},"reference-count":68,"publisher":"SCIE Publishing Limited","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.70322\/fibrosis.2026.10008","type":"journal-article","created":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T06:01:34Z","timestamp":1778824894000},"page":"10008-10008","source":"Crossref","is-referenced-by-count":0,"title":["Comparison of the Transcriptomic Signatures of Skin and Lung Fibroblasts from Patients with Systemic Sclerosis"],"prefix":"10.70322","volume":"4","author":[{"given":"E. Kotz","family":"Samantha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renaud","family":"Ludivine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. Feghali-Bostwick","family":"Carol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"51073","reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"Abraham DJ, Varga J. Scleroderma: From cell and molecular mechanisms to disease models. Trends Immunol. 2005, 26, 587-595. DOI:10.1016\/j.it.2005.09.004 [Google Scholar]","DOI":"10.1016\/j.it.2005.09.004"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Mayes MD, Lacey JV, Jr., Beebe-Dimmer J, Gillespie BW, Cooper B, Laing TJ, et al. Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population. Arthritis Rheum. 2003, 48, 2246-2255. DOI:10.1002\/art.11073 [Google Scholar]","DOI":"10.1002\/art.11073"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Peoples C, Medsger TA, Jr., Lucas M, Rosario BL, Feghali-Bostwick CA. Gender differences in systemic sclerosis: Relationship to clinical features, serologic status and outcomes. J. Scleroderma Relat. Disord. 2016, 1, 204-212. DOI:10.5301\/jsrd.5000209 [Google Scholar]","DOI":"10.5301\/jsrd.5000209"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Hachulla E, Launay D. Diagnosis and classification of systemic sclerosis. Clin. Rev. Allergy Immunol. 2011, 40, 78-83. DOI:10.1007\/s12016-010-8198-y [Google Scholar]","DOI":"10.1007\/s12016-010-8198-y"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Steen VD, Medsger TA, Jr. Severe organ involvement in systemic sclerosis with diffuse scleroderma. Arthritis Rheum. Off. J. Am. Coll. Rheumatol. 2000, 43, 2437-2444. DOI:10.1002\/1529-0131(200011)43:11%3C2437::AID-ANR10%3E3.0.CO;2-U [Google Scholar]","DOI":"10.1002\/1529-0131(200011)43:11<2437::AID-ANR10>3.0.CO;2-U"},{"key":"ref5","unstructured":"Medsger TAJ. Systemic sclerosis (scleroderma): Clinical aspects. In Arthritis and Allied Conditions: A Textbook of Rheumatology; Koopman WJ, Ed.; Williams & Wilkins: Baltimore, MD, USA, 1997; pp. 1433-1464. [Google Scholar]"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Steen V, Medsger T. Systemic sclerosis (scleroderma). In Prognosis in the Rheumatic Diseases; Springer: Berlin\/Heidelberg, Germany, 1991; pp. 213-231. [Google Scholar]","DOI":"10.1007\/978-94-011-3896-3_10"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Ruaro B, Soldano S, Smith V, Paolino S, Contini P, Montagna P, et al. Correlation between circulating fibrocytes and dermal thickness in limited cutaneous systemic sclerosis patients: A pilot study. Rheumatol. Int. 2019, 39, 1369-1376. DOI:10.1007\/s00296-019-04315-7 [Google Scholar]","DOI":"10.1007\/s00296-019-04315-7"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Cottin V, Brown KK. Interstitial lung disease associated with systemic sclerosis (SSc-ILD). Respir. Res. 2019, 20, 13. DOI:10.1186\/s12931-019-0980-7 [Google Scholar]","DOI":"10.1186\/s12931-019-0980-7"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Steen VD, Medsger TA. Changes in causes of death in systemic sclerosis, 1972-2002. Ann. Rheum. Dis. 2007, 66, 940-944. DOI:10.1136\/ard.2006.066068 [Google Scholar]","DOI":"10.1136\/ard.2006.066068"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Garrett SM, Baker Frost D, Feghali-Bostwick C. The mighty fibroblast and its utility in scleroderma research. J. Scleroderma Relat. Disord. 2017, 2, 100-107. DOI:10.5301\/jsrd.5000240 [Google Scholar]","DOI":"10.5301\/jsrd.5000240"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Romano E, Rosa I, Fioretto BS, Matucci-Cerinic M, Manetti M. The role of pro-fibrotic myofibroblasts in systemic sclerosis: From origin to therapeutic targeting. Curr. Mol. Med. 2022, 22, 209-239. DOI:10.2174\/0929867328666210325102749 [Google Scholar]","DOI":"10.2174\/0929867328666210325102749"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Phan SH. Biology of fibroblasts and myofibroblasts. Proc. Am. Thorac. Soc. 2008, 5, 334-337. DOI:10.1513\/pats.200708-146DR [Google Scholar]","DOI":"10.1513\/pats.200708-146DR"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Renaud L, Waldrep KM, da Silveira WA, Pilewski JM, Feghali-Bostwick CA. First Characterization of the Transcriptome of Lung Fibroblasts of SSc Patients and Healthy Donors of African Ancestry. Int. J. Mol. Sci. 2023, 24, 3645. DOI:10.3390\/ijms24043645 [Google Scholar]","DOI":"10.3390\/ijms24043645"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Malaab M, Renaud L, Takamura N, Zimmerman KD, da Silveira WA, Ramos PS, et al. Anti-fibrotic factor KLF4 is repressed by the miR-10\/TFAP2A\/TBX5 axis in dermal fibroblasts: Insights from twins discordant for systemic sclerosis. Ann. Rheum. Dis. 2022, 81, 268-277. DOI:10.1136\/annrheumdis-2021-221050 [Google Scholar]","DOI":"10.1136\/annrheumdis-2021-221050"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014, 15, 550. DOI:10.1186\/s13059-014-0550-8 [Google Scholar]","DOI":"10.1186\/s13059-014-0550-8"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Roach KM, Duffy SM, Coward W, Feghali-Bostwick C, Wulff H, Bradding P. The K+ channel KCa3.1 as a novel target for idiopathic pulmonary fibrosis. PLoS ONE 2013, 8, e85244. DOI:10.1371\/journal.pone.0085244 [Google Scholar]","DOI":"10.1371\/journal.pone.0085244"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Wu C-Y, Hsu W-L, Tsai M-H, Chai C-Y, Yen C-J, Chen C-H, et al. A potential new approach for treating systemic sclerosis: Dedifferentiation of SSc fibroblasts and change in the microenvironment by blocking store-operated Ca2+ entry. PLoS ONE 2019, 14, e0213400. DOI:10.1371\/journal.pone.0213400 [Google Scholar]","DOI":"10.1371\/journal.pone.0213400"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Kittana N. Calcium signaling in cardiac fibroblasts: Roles in fibrosis and therapeutic implications. Cardiovasc. Drugs Ther. 2026, 40, 393-410. DOI:10.1007\/s10557-025-07699-w [Google Scholar]","DOI":"10.1007\/s10557-025-07699-w"},{"key":"ref19","unstructured":"Atanelishvili I, Akter T, Noguchi A, Vuyiv O, Wollin L, Silver RM, et al. Anti-fibrotic efficacy of nintedanib in a cellular model of systemic sclerosis-associated interstitial lung disease. Clin. Exp. Rheumatol. 2019, 37, 115-124. [Google Scholar]"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Roach KM, Wulff H, Feghali-Bostwick C, Amrani Y, Bradding P. Increased constitutive \u03b1SMA and Smad2\/3 expression in idiopathic pulmonary fibrosis myofibroblasts is KCa3.1-dependent. Respir. Res. 2014, 15, 155. DOI:10.1186\/s12931-014-0155-5 [Google Scholar]","DOI":"10.1186\/s12931-014-0155-5"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Xu D, Li T, Wang R, Mu R. Expression and pathogenic analysis of integrin family genes in systemic sclerosis. Front. Med. 2021, 8, 674523. DOI:10.3389\/fmed.2021.674523 [Google Scholar]","DOI":"10.3389\/fmed.2021.674523"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Paine R, Ward PA. Cell adhesion molecules and pulmonary fibrosis. Am. J. Med. 1999, 107, 268-279. DOI:10.1016\/S0002-9343(99)00226-0 [Google Scholar]","DOI":"10.1016\/S0002-9343(99)00226-0"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Dufour AM, Alvarez M, Russo B, Chizzolini C. Interleukin-6 and type-I collagen production by systemic sclerosis fibroblasts are differentially regulated by interleukin-17A in the presence of transforming growth factor-beta 1. Front. Immunol. 2018, 9, 1865. DOI:10.3389\/fimmu.2018.01865 [Google Scholar]","DOI":"10.3389\/fimmu.2018.01865"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Feghali CA, Bost KL, Boulware DW, Levy LS. Control of IL-6 expression and response in fibroblasts from patients with systemic sclerosis. Autoimmunity 1994, 17, 309-318. DOI:10.3109\/08916939409010671 [Google Scholar]","DOI":"10.3109\/08916939409010671"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Shima Y. Cytokines involved in the pathogenesis of SSc and problems in the development of anti-cytokine therapy. Cells 2021, 10, 1104. DOI:10.3390\/cells10051104 [Google Scholar]","DOI":"10.3390\/cells10051104"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Forte E, Ramialison M, Nim HT, Mara M, Li JY, Cohn R, et al. Adult mouse fibroblasts retain organ-specific transcriptomic identity. Elife 2022, 11, e71008. DOI:10.7554\/eLife.71008 [Google Scholar]","DOI":"10.7554\/eLife.71008"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Hung CF, Rohani MG, Lee S-S, Chen P, Schnapp LM. Role of IGF-1 pathway in lung fibroblast activation. Respir. Res. 2013, 14, 102. DOI:10.1186\/1465-9921-14-102 [Google Scholar]","DOI":"10.1186\/1465-9921-14-102"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Pilewski JM, Liu L, Henry AC, Knauer AV, Feghali-Bostwick CA. Insulin-like growth factor binding proteins 3 and 5 are overexpressed in idiopathic pulmonary fibrosis and contribute to extracellular matrix deposition. Am. J. Pathol. 2005, 166, 399-407. DOI:10.1016\/S0002-9440(10)62263-8 [Google Scholar]","DOI":"10.1016\/S0002-9440(10)62263-8"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Veraldi KL, Feghali-Bostwick CA. Insulin-like growth factor binding proteins-3 and-5: Central mediators of fibrosis and promising new therapeutic targets. Open Rheumatol. J. 2012, 6, 140-145. DOI:10.2174\/1874312901206010140 [Google Scholar]","DOI":"10.2174\/1874312901206010140"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"Yasuoka H, Yamaguchi Y, Feghali-Bostwick CA. The pro-fibrotic factor IGFBP-5 induces lung fibroblast and mononuclear cell migration. Am. J. Respir. Cell Mol. Biol. 2009, 41, 179-188. DOI:10.1165\/rcmb.2008-0211OC [Google Scholar]","DOI":"10.1165\/rcmb.2008-0211OC"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"Nguyen X-X, Nishimoto T, Takihara T, Mlakar L, Bradshaw AD, Feghali-Bostwick C. Lysyl oxidase directly contributes to extracellular matrix production and fibrosis in systemic sclerosis. Am. J. Physiol.-Lung Cell. Mol. Physiol. 2021, 320, L29-L40. DOI:10.1152\/ajplung.00173.2020 [Google Scholar]","DOI":"10.1152\/ajplung.00173.2020"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"Sun T, Huang Z, Liang W-C, Yin J, Lin WY, Wu J, et al. TGF\u03b22 and TGF\u03b23 isoforms drive fibrotic disease pathogenesis. Sci. Transl. Med. 2021, 13, eabe0407. DOI:10.1126\/scitranslmed.abe0407 [Google Scholar]","DOI":"10.1126\/scitranslmed.abe0407"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"Garrett SM, Hsu E, Thomas JM, Pilewski JM, Feghali-Bostwick C. Insulin-like growth factor (IGF)-II-mediated fibrosis in pathogenic lung conditions. PLoS ONE 2019, 14, e0225422. DOI:10.1371\/journal.pone.0225422 [Google Scholar]","DOI":"10.1371\/journal.pone.0225422"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"Sun T, Vander Heiden JA, Gao X, Yin J, Uttarwar S, Liang W-C, et al. Isoform-selective TGF-\u03b23 inhibition for systemic sclerosis. Med 2024, 5, 132-147.e7. DOI:10.1016\/j.medj.2023.12.011 [Google Scholar]","DOI":"10.1016\/j.medj.2023.12.011"},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"Allanore Y. Limited cutaneous systemic sclerosis: The unfairly neglected subset. J. Scleroderma Relat. Disord. 2016, 1, 241-246. DOI:10.5301\/jsrd.5000216 [Google Scholar]","DOI":"10.5301\/jsrd.5000216"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"Yamaguchi Y, Ono J, Masuoka M, Ohta S, Izuhara K, Ikezawa Z, et al. Serum periostin levels are correlated with progressive skin sclerosis in patients with systemic sclerosis. Br. J. Dermatol. 2013, 168, 717-725. DOI:10.1111\/bjd.12117 [Google Scholar]","DOI":"10.1111\/bjd.12117"},{"key":"ref37","doi-asserted-by":"publisher","unstructured":"Yoshihara T, Nanri Y, Nunomura S, Yamaguchi Y, Feghali-Bostwick C, Ajito K, et al. Periostin plays a critical role in the cell cycle in lung fibroblasts. Respir. Res. 2020, 21, 38. DOI:10.1186\/s12931-020-1299-0 [Google Scholar]","DOI":"10.1186\/s12931-020-1299-0"},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"Maldonado M, Salgado-Aguayo A, Herrera I, Cabrera S, Ort\u00edz-Quintero B, Staab-Weijnitz CA, et al. Upregulation and nuclear location of MMP28 in alveolar epithelium of idiopathic pulmonary fibrosis. Am. J. Respir. Cell Mol. Biol. 2018, 59, 77-86. DOI:10.1165\/rcmb.2017-0223OC [Google Scholar]","DOI":"10.1165\/rcmb.2017-0223OC"},{"key":"ref39","doi-asserted-by":"publisher","unstructured":"Ferreras M, Felbor U, Lenhard T, Olsen BR, Delaiss\u00e9 J-M. Generation and degradation of human endostatin proteins by various proteinases. FEBS Lett. 2000, 486, 247-251. DOI:10.1016\/S0014-5793(00)02249-3 [Google Scholar]","DOI":"10.1016\/S0014-5793(00)02249-3"},{"key":"ref40","doi-asserted-by":"publisher","unstructured":"Mouawad JE, Sharma S, Renaud L, Pilewski JM, Nadig SN, Feghali-Bostwick C. Reduced Cathepsin L expression and secretion into the extracellular milieu contribute to lung fibrosis in systemic sclerosis. Rheumatology 2023, 62, 1306-1316. DOI:10.1093\/rheumatology\/keac411 [Google Scholar]","DOI":"10.1093\/rheumatology\/keac411"},{"key":"ref41","doi-asserted-by":"publisher","unstructured":"Yamaguchi Y, Takihara T, Chambers RA, Veraldi KL, Larregina AT, Feghali-Bostwick CA. A peptide derived from endostatin ameliorates organ fibrosis. Sci. Transl. Med. 2012, 4, ra171-ra136. DOI:10.1126\/scitranslmed.3003421 [Google Scholar]","DOI":"10.1126\/scitranslmed.3003421"},{"key":"ref42","doi-asserted-by":"publisher","unstructured":"Sharma S, Watanabe T, Nishimoto T, Takihara T, Mlakar L, Nguyen X-X, et al. E4 engages uPAR and enolase-1 and activates urokinase to exert anti-fibrotic effects. JCI Insight 2021, 6, e144935. DOI:10.1172\/jci.insight.144935 [Google Scholar]","DOI":"10.1172\/jci.insight.144935"},{"key":"ref43","doi-asserted-by":"publisher","unstructured":"Ota C, Ng-Blichfeldt J-P, Korfei M, Alsafadi HN, Lehmann M, Skronska-Wasek W, et al. Dynamic expression of HOPX in alveolar epithelial cells reflects injury and repair during the progression of pulmonary fibrosis. Sci. Rep. 2018, 8, 12983. DOI:10.1038\/s41598-018-31214-x [Google Scholar]","DOI":"10.1038\/s41598-018-31214-x"},{"key":"ref44","unstructured":"Feghali CA. Regulation of Fibroblast Function in Systemic Sclerosis; Tulane University: New Orleans, LA, USA, 1992. [Google Scholar]"},{"key":"ref45","doi-asserted-by":"publisher","unstructured":"Fang D, Yuan X, Yi J, Li Z, Li X, Guo W, et al. Targeting PTGDS inhibits pro-inflammatory fibroblasts associated with skin fibrosis in systemic sclerosis. Rheumatology 2025, 64, 5551-5561. DOI:10.1093\/rheumatology\/keaf276 [Google Scholar]","DOI":"10.1093\/rheumatology\/keaf276"},{"key":"ref46","doi-asserted-by":"publisher","unstructured":"\u00dcnl\u00fc B, T\u00fcrsen \u00dc, Rajabi Z, Jabalameli N, Rajabi F. The immunogenetics of systemic sclerosis. In The Immunogenetics of Dermatologic Diseases; Springer: Berlin\/Heidelberg, Germany, 2022; pp. 259-298. [Google Scholar]","DOI":"10.1007\/978-3-030-92616-8_10"},{"key":"ref47","doi-asserted-by":"publisher","unstructured":"Ye RD, Sun L. Emerging functions of serum amyloid A in inflammation. J. Leucoc. Biol. 2015, 98, 923-929. DOI:10.1189\/jlb.3VMR0315-080R [Google Scholar]","DOI":"10.1189\/jlb.3VMR0315-080R"},{"key":"ref48","doi-asserted-by":"publisher","unstructured":"Tsukui T, Wolters PJ, Sheppard D. Alveolar fibroblast lineage orchestrates lung inflammation and fibrosis. Nature 2024, 631, 627-634. DOI:10.1038\/s41586-024-07660-1 [Google Scholar]","DOI":"10.1038\/s41586-024-07660-1"},{"key":"ref49","doi-asserted-by":"publisher","unstructured":"Brandenberger R, Schmidt A, Linton J, Wang D, Backus C, Denda S, et al. Identification and characterization of a novel extracellular matrix protein nephronectin that is associated with integrin \u03b18\u03b21 in the embryonic kidney. J. Cell Biol. 2001, 154, 447-458. DOI:10.1083\/jcb.200103069 [Google Scholar]","DOI":"10.1083\/jcb.200103069"},{"key":"ref50","doi-asserted-by":"publisher","unstructured":"Drabek K, van de Peppel J, Eijken M, van Leeuwen JP. GPM6B regulates osteoblast function and induction of mineralization by controlling cytoskeleton and matrix vesicle release. J. Bone Miner. Res. 2011, 26, 2045-2051. DOI:10.1002\/jbmr.435 [Google Scholar]","DOI":"10.1002\/jbmr.435"},{"key":"ref51","doi-asserted-by":"publisher","unstructured":"Murata H, Zhou L, Ochoa S, Hasan A, Badiavas E, Falanga V. TGF-\u03b23 stimulates and regulates collagen synthesis through TGF-\u03b21-dependent and independent mechanisms. J. Investig. Dermatol. 1997, 108, 258-262. DOI:10.1111\/1523-1747.ep12286451 [Google Scholar]","DOI":"10.1111\/1523-1747.ep12286451"},{"key":"ref52","doi-asserted-by":"publisher","unstructured":"Je Y-J, Choi D-K, Sohn K-C, Kim H-R, Im M, Lee Y, et al. Inhibitory role of Id1 on TGF-\u03b2-induced collagen expression in human dermal fibroblasts. Biochem. Biophys. Res. Commun. 2014, 444, 81-85. DOI:10.1016\/j.bbrc.2014.01.010 [Google Scholar]","DOI":"10.1016\/j.bbrc.2014.01.010"},{"key":"ref53","doi-asserted-by":"publisher","unstructured":"Li X, Ma T-K, Wang P, Shi H, Hai S, Qin Y, et al. HOXD10 attenuates renal fibrosis by inhibiting NOX4-induced ferroptosis. Cell Death Dis. 2024, 15, 398. DOI:10.1038\/s41419-024-06780-w [Google Scholar]","DOI":"10.1038\/s41419-024-06780-w"},{"key":"ref54","doi-asserted-by":"publisher","unstructured":"Li L, Ran J, Li L, Chen G, Zhang S, Wang Y. Gli3 is a novel downstream target of miR-200a with an anti-fibrotic role for progression of liver fibrosis in vivo and in vitro. Mol. Med. Rep. 2020, 21, 1861-1871. DOI:10.3892\/mmr.2020.10997 [Google Scholar]","DOI":"10.3892\/mmr.2020.10997"},{"key":"ref55","doi-asserted-by":"publisher","unstructured":"Wu K, Ma F, Shen J, Zhang H, Wan Y, He X, et al. LncRNA FPASL suppresses fibroblast proliferation through its DNA methylation via DNMT3b in hypertrophic scar: DNMT3b-mediated lncRNA FPASL in fibroblast proliferation. Acta Biochim. et Biophys. Sin. 2022, 54, 1854-1862. DOI:10.3724\/abbs.2022181 [Google Scholar]","DOI":"10.3724\/abbs.2022181"},{"key":"ref56","doi-asserted-by":"publisher","unstructured":"Takamura N, Renaud L, da Silveira WA, Feghali-Bostwick C. PDGF promotes dermal fibroblast activation via a novel mechanism mediated by signaling through MCHR1. Front. Immunol. 2021, 12, 745308. DOI:10.3389\/fimmu.2021.745308 [Google Scholar]","DOI":"10.3389\/fimmu.2021.745308"},{"key":"ref57","doi-asserted-by":"publisher","unstructured":"Hsu E, Feghali-Bostwick CA. Insulin-like growth factor-II is increased in systemic sclerosis-associated pulmonary fibrosis and contributes to the fibrotic process via Jun N-terminal kinase-and phosphatidylinositol-3 kinase-dependent pathways. Am. J. Pathol. 2008, 172, 1580-1590. DOI:10.2353\/ajpath.2008.071021 [Google Scholar]","DOI":"10.2353\/ajpath.2008.071021"},{"key":"ref58","doi-asserted-by":"publisher","unstructured":"Waldrep KM, Rodgers JI, Garrett SM, Wolf BJ, Feghali-Bostwick CA. The role of SOX9 in IGF-II-mediated pulmonary fibrosis. Int. J. Mol. Sci. 2023, 24, 11234. DOI:10.3390\/ijms241411234 [Google Scholar]","DOI":"10.3390\/ijms241411234"},{"key":"ref59","doi-asserted-by":"publisher","unstructured":"Salamito M, Nauroy P, Ruggiero F. The collagen superfamily: Everything you always wanted to know. In The Collagen Superfamily and Collagenopathies; Springer: Berlin\/Heidelberg, Germany, 2021; pp. 1-22. [Google Scholar]","DOI":"10.1007\/978-3-030-67592-9_1"},{"key":"ref60","doi-asserted-by":"publisher","unstructured":"Watanabe T, Baker Frost D, Mlakar L, Heywood J, da Silveira WA, Hardiman G, et al. A human skin model recapitulates systemic sclerosis dermal fibrosis and identifies COL22A1 as a TGF\u03b2 early response gene that mediates fibroblast to myofibroblast transition. Genes 2019, 10, 75. DOI:10.3390\/genes10020075 [Google Scholar]","DOI":"10.3390\/genes10020075"},{"key":"ref61","doi-asserted-by":"publisher","unstructured":"Mar\u010deti\u0107 M, Bufan B, Drobac M, Anti\u0107 Stankovi\u0107 J, Arsenovi\u0107 Ranin N, Milenkovi\u0107 MT, et al. Multifaceted biological properties of verbascoside\/acteoside: Antimicrobial, cytotoxic, anti-inflammatory, and immunomodulatory effects. Antibiotics 2025, 14, 697. DOI:10.3390\/antibiotics14070697 [Google Scholar]","DOI":"10.3390\/antibiotics14070697"},{"key":"ref62","doi-asserted-by":"publisher","unstructured":"Xiao Y, Ren Q, Wu L. The pharmacokinetic property and pharmacological activity of acteoside: A review. Biomed. Pharmacother. 2022, 153, 113296. DOI:10.1016\/j.biopha.2022.113296 [Google Scholar]","DOI":"10.1016\/j.biopha.2022.113296"},{"key":"ref63","doi-asserted-by":"publisher","unstructured":"Chen C-Y, Tung H-Y, Tseng Y-F, Huang J-S, Shi L-S, Ye Y-L. Verbascoside and isoverbascoside ameliorate transforming growth factor \u03b21-induced collagen expression by lung fibroblasts through Smad\/non-Smad signaling pathways. Life Sci. 2022, 308, 120950. DOI:10.1016\/j.lfs.2022.120950 [Google Scholar]","DOI":"10.1016\/j.lfs.2022.120950"},{"key":"ref64","doi-asserted-by":"publisher","unstructured":"Zhou M, Zhang S, Bai X, Cai Y, Zhang Z, Zhang P, et al. Acteoside delays the fibrosis process of diabetic nephropathy by anti-oxidation and regulating the autophagy-lysosome pathway. Eur. J. Pharmacol. 2024, 978, 176715. DOI:10.1016\/j.ejphar.2024.176715 [Google Scholar]","DOI":"10.1016\/j.ejphar.2024.176715"},{"key":"ref65","doi-asserted-by":"publisher","unstructured":"Roth M, Eickelberg O, Kohler E, Erne P, Block LH. Ca2+ channel blockers modulate metabolism of collagens within the extracellular matrix. Proc. Natl. Acad. Sci. USA 1996, 93, 5478-5482. DOI:10.1073\/pnas.93.11.5478 [Google Scholar]","DOI":"10.1073\/pnas.93.11.5478"},{"key":"ref66","doi-asserted-by":"publisher","unstructured":"Liao C-T, Lin Y-C, Huang H-J, Liu W-C, Kan W-C, Chiu H-W. Docking and database screening identify manidipine as a potential modulator of matrix metalloproteinase-7 in chronic kidney disease. Biomed. Pharmacother. 2025, 193, 118748. DOI:10.1016\/j.biopha.2025.118748 [Google Scholar]","DOI":"10.1016\/j.biopha.2025.118748"},{"key":"ref67","doi-asserted-by":"publisher","unstructured":"Baker Frost D, Savchenko A, Takamura N, Wolf B, Fierkens R, King K, et al. A positive feedback loop exists between estradiol and IL-6 and contributes to dermal fibrosis. Int. J. Mol. Sci. 2024, 25, 7227. DOI:10.3390\/ijms25137227 [Google Scholar]","DOI":"10.3390\/ijms25137227"}],"container-title":["Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.sciepublish.com\/article\/pii\/1012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T08:06:24Z","timestamp":1779177984000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.sciepublish.com\/article\/pii\/1012"}},"subtitle":[""],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":68,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.70322\/fibrosis.2026.10008","relation":{},"ISSN":["2959-605X"],"issn-type":[{"value":"2959-605X","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]}}}